Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16349 studies found for:    ( NOT NOTEXT ) [FIRST-RECEIVED-RESULTS-DATE]
Show Display Options
Rank Status Study
1 Completed
Has Results
Long Term Administration Study of OPC-12759 Ophthalmic Suspension
Condition: Dry Eye Syndromes
Intervention: Drug: OPC-12759 Ophthalmic suspension
2 Terminated
Has Results
Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403
Condition: Arthritis, Rheumatoid
Intervention: Drug: ofatumumab
3 Completed
Has Results
Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients
Condition: HIV Infections
4 Completed
Has Results
Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: colesevelam HCl;   Drug: placebo
5 Completed
Has Results
Telephone-based Care for OEF/OIF Veterans With PTSD
Condition: Post-Traumatic Stress Disorder
Intervention: Other: Phone-based outreach
6 Completed
Has Results
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
Conditions: Lung Neoplasms;   Carcinoma;   Cancer of the Lung;   Non-Small-Cell Lung Carcinoma
Interventions: Drug: Cetuximab;   Drug: Cisplatin;   Drug: Vinorelbine
7 Completed
Has Results
Piloting IVR (Interactive Voice Response) for Chronic Pain Treatment
Condition: Chronic Pain
Intervention: Behavioral: IVR-based Cognitive-behavior therapy
8 Completed
Has Results
Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514)
Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir;   Biological: Peginterferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908)
9 Completed
Has Results
Prasugrel/Clopidogrel Maintenance Dose Washout Study
Condition: Coronary Artery Disease
Interventions: Drug: prasugrel;   Drug: clopidogrel
10 Completed
Has Results
Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer
Condition: Chronic Kidney Failure
11 Terminated
Has Results
Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: Zalutumumab
12 Completed
Has Results
Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer
Conditions: Breast Cancer;   Breast Tumors;   Neoplasms, Breast;   Cancer of the Breast;   Human Mammary Carcinoma
Interventions: Drug: Pralatrexate Injection;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic Acid
13 Completed
Has Results
A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss
Conditions: Diabetes Mellitus;   Obesity
Interventions: Behavioral: Low carbohydrate ketogenic diet;   Drug: Orlistat;   Behavioral: Low-fat diet
14 Completed
Has Results
An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Technosphere® Insulin Inhalation Powder and MedTone™ Inhaler
15 Terminated
Has Results
Sandostatin for Patients With Androgen Independent Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Sandostatin
16 Completed
Has Results
Efficacy of Naltrexone in Women's Smoking Cessation
Conditions: Smoking;   Smoking Cessation
Interventions: Drug: Naltrexone (drug);   Drug: Placebo (for Naltrexone)
17 Completed
Has Results
D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: D-cycloserine;   Drug: Placebo;   Behavioral: Cognitive Remediation
18 Active, not recruiting
Has Results
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: prednisone;   Drug: vincristine
19 Completed
Has Results
Efficacy Study of a Facemask Device to Treat Hypotension
Condition: Hypotension
Interventions: Device: Impedance Threshold Device;   Device: sham ITD
20 Completed
Has Results
Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions
Condition: Healthy
Intervention: Drug: Alprazolam Extended-Release 3 mg Tablets

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years